Biobide is a Contract Research Organization (CRO) company offering drug discovery services to Pharma, Biotech, Chemical, Cosmetic, and Nutraceutical companies. Our service is based on the zebrafish model and the capacity to offer highly efficient tailor-made assays.
ALS is a neurodegenerative disease characterized by the degeneration of motor neurons, which causes a loss of muscle strength and eventually paralysis. Several gene mutations have been associated to ALS, including SOD1 and C9orf72.
Zebrafish model is a valuable tool for Drug Discovery research due to its unique advantages: low cost, external fertilization, fast development, transparency, and high biological relevance. A screening assay using two zebrafish transgenic lines (Tg(sod1:sod1_G93R,hsp70l:DsRed) and Tg(ubb:zgc:100846_89xCCCCGG,hsp70l:DsRed)) has been developed to identify potential therapies for ALS.